CN102154200A - 临床治疗用脐带间充质干细胞的制备和保存 - Google Patents
临床治疗用脐带间充质干细胞的制备和保存 Download PDFInfo
- Publication number
- CN102154200A CN102154200A CN 201010585066 CN201010585066A CN102154200A CN 102154200 A CN102154200 A CN 102154200A CN 201010585066 CN201010585066 CN 201010585066 CN 201010585066 A CN201010585066 A CN 201010585066A CN 102154200 A CN102154200 A CN 102154200A
- Authority
- CN
- China
- Prior art keywords
- gentamicin
- cell
- umbilical cord
- calf serum
- tissue block
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 210000002901 mesenchymal stem cell Anatomy 0.000 title abstract description 11
- 210000003954 umbilical cord Anatomy 0.000 claims abstract description 51
- 210000004027 cell Anatomy 0.000 claims abstract description 46
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 26
- 239000002504 physiological saline solution Substances 0.000 claims abstract description 25
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 13
- 108010019160 Pancreatin Proteins 0.000 claims abstract description 8
- 238000012258 culturing Methods 0.000 claims abstract description 8
- 229940055695 pancreatin Drugs 0.000 claims abstract description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 3
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 41
- 229930182566 Gentamicin Natural products 0.000 claims description 41
- 229960002518 gentamicin Drugs 0.000 claims description 41
- 244000309466 calf Species 0.000 claims description 30
- 210000002966 serum Anatomy 0.000 claims description 30
- 210000000130 stem cell Anatomy 0.000 claims description 23
- 238000000703 high-speed centrifugation Methods 0.000 claims description 18
- 230000003321 amplification Effects 0.000 claims description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 13
- 230000001464 adherent effect Effects 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 7
- 208000007536 Thrombosis Diseases 0.000 claims description 6
- 210000001367 artery Anatomy 0.000 claims description 6
- 210000004691 chief cell of stomach Anatomy 0.000 claims description 6
- 238000005138 cryopreservation Methods 0.000 claims description 6
- 210000002249 digestive system Anatomy 0.000 claims description 6
- 230000001605 fetal effect Effects 0.000 claims description 6
- 230000004927 fusion Effects 0.000 claims description 6
- 230000008520 organization Effects 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 230000002792 vascular Effects 0.000 claims description 6
- 230000002785 anti-thrombosis Effects 0.000 claims description 5
- 229960004676 antithrombotic agent Drugs 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 238000007710 freezing Methods 0.000 abstract description 4
- 230000008014 freezing Effects 0.000 abstract description 4
- 239000007758 minimum essential medium Substances 0.000 abstract description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract 2
- 229960001484 edetic acid Drugs 0.000 abstract 2
- 239000012894 fetal calf serum Substances 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 230000007910 cell fusion Effects 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 238000010008 shearing Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 34
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 12
- 230000004069 differentiation Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000024908 graft versus host disease Diseases 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000003668 pericyte Anatomy 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000003995 blood forming stem cell Anatomy 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 102100022464 5'-nucleotidase Human genes 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 208000020339 Spinal injury Diseases 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000011281 clinical therapy Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 210000001074 muscle attachment cell Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010585066 CN102154200B (zh) | 2010-12-13 | 2010-12-13 | 临床治疗用脐带间充质干细胞的制备和保存 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010585066 CN102154200B (zh) | 2010-12-13 | 2010-12-13 | 临床治疗用脐带间充质干细胞的制备和保存 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102154200A true CN102154200A (zh) | 2011-08-17 |
CN102154200B CN102154200B (zh) | 2012-10-03 |
Family
ID=44435875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010585066 Expired - Fee Related CN102154200B (zh) | 2010-12-13 | 2010-12-13 | 临床治疗用脐带间充质干细胞的制备和保存 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102154200B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102511471A (zh) * | 2011-12-15 | 2012-06-27 | 成都清科生物科技有限公司 | 一种间充质干细胞冻存液及其制备方法 |
CN104839146A (zh) * | 2015-05-29 | 2015-08-19 | 广州赛莱拉干细胞科技股份有限公司 | 组合物及其用途、胎盘保存制剂及其制备方法 |
CN106719601A (zh) * | 2016-11-30 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | 一种脐带保存液及其应用 |
CN107114356A (zh) * | 2016-08-01 | 2017-09-01 | 北京世纪劲得生物技术有限公司 | 一种胎盘及脐带细胞保护液 |
CN107653226A (zh) * | 2017-11-15 | 2018-02-02 | 南京三生生物技术股份有限公司 | 一种人脐带间充质干细胞分离培养方法 |
CN110540959A (zh) * | 2019-10-08 | 2019-12-06 | 孟明耀 | 一种脐带间充质干细胞分离培养扩增方法 |
CN111955454A (zh) * | 2020-05-14 | 2020-11-20 | 领航干细胞再生医学工程有限公司 | 一种人离体牙保存液及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107779430A (zh) * | 2016-08-30 | 2018-03-09 | 天津市康婷生物工程有限公司 | 脐带间充质干细胞上清液的收集方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050045325A (ko) * | 2003-11-11 | 2005-05-17 | (주)히스토스템 | 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법 |
CN101591644A (zh) * | 2009-04-13 | 2009-12-02 | 中国人民解放军第三○二医院 | 临床治疗用脐带间充质干细胞的制备和储存 |
-
2010
- 2010-12-13 CN CN 201010585066 patent/CN102154200B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050045325A (ko) * | 2003-11-11 | 2005-05-17 | (주)히스토스템 | 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법 |
CN1878860A (zh) * | 2003-11-11 | 2006-12-13 | 韩薰 | 分离和培养来自脐带血的间充质干细胞的方法 |
CN101591644A (zh) * | 2009-04-13 | 2009-12-02 | 中国人民解放军第三○二医院 | 临床治疗用脐带间充质干细胞的制备和储存 |
Non-Patent Citations (1)
Title |
---|
《Int J Hematol》 20090806 Ikuo Ishige et. al Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord 261-269 第90卷, * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102511471A (zh) * | 2011-12-15 | 2012-06-27 | 成都清科生物科技有限公司 | 一种间充质干细胞冻存液及其制备方法 |
CN102511471B (zh) * | 2011-12-15 | 2013-08-28 | 成都清科生物科技有限公司 | 一种间充质干细胞冻存液及其制备方法 |
CN104839146A (zh) * | 2015-05-29 | 2015-08-19 | 广州赛莱拉干细胞科技股份有限公司 | 组合物及其用途、胎盘保存制剂及其制备方法 |
CN107114356A (zh) * | 2016-08-01 | 2017-09-01 | 北京世纪劲得生物技术有限公司 | 一种胎盘及脐带细胞保护液 |
CN106719601A (zh) * | 2016-11-30 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | 一种脐带保存液及其应用 |
CN107653226A (zh) * | 2017-11-15 | 2018-02-02 | 南京三生生物技术股份有限公司 | 一种人脐带间充质干细胞分离培养方法 |
CN110540959A (zh) * | 2019-10-08 | 2019-12-06 | 孟明耀 | 一种脐带间充质干细胞分离培养扩增方法 |
CN111955454A (zh) * | 2020-05-14 | 2020-11-20 | 领航干细胞再生医学工程有限公司 | 一种人离体牙保存液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102154200B (zh) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102154200B (zh) | 临床治疗用脐带间充质干细胞的制备和保存 | |
CN102807966B (zh) | 胎盘全细胞冻存、复苏以及分离和扩增干细胞的方法 | |
CN102660497B (zh) | 脐带组织冻存、复苏以及分离和扩增干细胞的方法 | |
CN105238751B (zh) | 一种脐带组织间充质干细胞的分离培养方法 | |
CN101591644A (zh) | 临床治疗用脐带间充质干细胞的制备和储存 | |
CN106434557B (zh) | 由脐带间充质干细胞制备cd34阳性细胞的方法 | |
CN107164319B (zh) | 一种原代培养犬脐带来源的间充质干细胞的方法 | |
CN101922048B (zh) | 一种脐带间充质干细胞公共库的建库方法 | |
CN107746829B (zh) | 一种分离与原代培养犬胎盘来源的间充质干细胞的方法 | |
CN106801032B (zh) | 人羊膜上皮干细胞库的构建方法 | |
CN104762257B (zh) | 一种从脐带制备间充质干细胞的方法 | |
CN104450611A (zh) | 一种人羊膜间充质干细胞原代分离及培养方法 | |
CN104480533A (zh) | 一种胎盘干细胞库的构建方法及胎盘组织复苏方法 | |
CN102807967A (zh) | 乳牙牙髓在制备间充质干细胞中的应用和乳牙牙髓间充质干细胞的培养方法 | |
CN108220229A (zh) | 一种提高脐带来源间充质干细胞原代细胞产量的制备方法 | |
CN104673748A (zh) | 一种从人脐带中提取间充质干细胞的方法 | |
CN102660503A (zh) | 从脐带中分离和扩增间充质干细胞的方法 | |
CN102851255A (zh) | 一种高效快速分离人间充质干细胞的方法 | |
CN104651305A (zh) | 一种利用脐带间充质干细胞获取生物活性蛋白的方法 | |
CN104357382A (zh) | 人脂肪干细胞的获取方法及多级同种异体脂肪干细胞库的构建方法 | |
CN105647860A (zh) | 临床治疗级人胎盘底蜕膜来源的间充质干细胞(PDB-MSCs)无血清体外提取制备方法 | |
CN104531617A (zh) | 一种树突状细胞的制备方法、所得树突状细胞 | |
CN103421739A (zh) | 一种高效分离脐带间充质干细胞的方法 | |
CN105505865A (zh) | 一种脐带间充质干细胞的分离方法 | |
CN102191229A (zh) | 一种快速有效获得脐带间充质干细胞(msc)的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Fusheng Inventor after: Shi Ming Inventor after: Xu Ruonan Inventor after: Jin Lei Inventor before: Wang Fusheng Inventor before: Shi Ming Inventor before: Xu Ruonan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG FUSHENG SHI MING XU RUONAN TO: WANG FUSHENG SHI MING XU RUONAN JIN LEI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121003 Termination date: 20151213 |
|
EXPY | Termination of patent right or utility model |